Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials
出版年份 2018 全文链接
标题
Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials
作者
关键词
Anabolic, Antiresorptive, Bisphosphonates, Bone mineral density, Combination therapy, Denosumab, Osteoporosis, Teriparatide
出版物
OSTEOPOROSIS INTERNATIONAL
Volume 30, Issue 1, Pages 59-70
出版商
Springer Nature
发表日期
2018-12-12
DOI
10.1007/s00198-018-4790-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Combined Pharmacologic Therapy in Postmenopausal Osteoporosis
- (2017) Yang Shen et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Two-year clinical outcome of denosumab treatment alone and in combination with teriparatide in Japanese treatment-naive postmenopausal osteoporotic women
- (2017) Yukio Nakamura et al. Bone Research
- Osteoporosis treatment: recent developments and ongoing challenges
- (2017) Sundeep Khosla et al. Lancet Diabetes & Endocrinology
- Using Osteoporosis Therapies in Combination
- (2017) Michael R. McClung Current Osteoporosis Reports
- Osteoporosis: Treat-to-Target
- (2017) E. Michael Lewiecki Current Osteoporosis Reports
- Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis
- (2016) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Teriparatide and denosumab combination therapy and skeletal metabolism
- (2016) L. Idolazzi et al. OSTEOPOROSIS INTERNATIONAL
- Antiresorptives and anabolic therapy in sequence or combination for postmenopausal osteoporosis
- (2015) S. Palacios et al. CLIMACTERIC
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
- (2014) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fracture mortality: associations with epidemiology and osteoporosis treatment
- (2014) Sebastian E. Sattui et al. Nature Reviews Endocrinology
- Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches
- (2014) Felicia Cosman Current Osteoporosis Reports
- Goal-directed treatment of osteoporosis
- (2013) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treat-to-target for Osteoporosis: Is Now the Time?
- (2013) E. Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk-a perspective
- (2012) Steven Boonen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density
- (2012) Christian Muschitz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Six Months of Parathyroid Hormone (1–84) Administered ConcurrentlyVersusSequentially with Monthly Ibandronate Over Two Years: The PTH and Ibandronate Combination Study (PICS) Randomized Trial
- (2012) Anne L. Schafer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparative Effectiveness of Drug Treatments to Prevent Fragility Fractures: A Systematic Review and Network Meta-Analysis
- (2012) Mohammad Hassan Murad et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Combination therapy: the Holy Grail for the treatment of postmenopausal osteoporosis?
- (2011) E. Michael Lewiecki CURRENT MEDICAL RESEARCH AND OPINION
- Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid
- (2011) Elie A. Akl et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Osteoporotic Fractures
- (2011) Sangeeta Budhia et al. PHARMACOECONOMICS
- Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis
- (2010) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
- (2010) Joel S. Finkelstein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent
- (2009) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Parathyroid Hormone(1–84) Treatment of Postmenopausal Women with Low Bone Mass Receiving Hormone Replacement Therapy
- (2008) I. Fogelman et al. CALCIFIED TISSUE INTERNATIONAL
- Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment
- (2008) Barbara M Obermayer-Pietsch et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinical Potential of RANKL Inhibition for the Management of Postmenopausal Osteoporosis and Other Metabolic Bone Diseases
- (2008) Pierre D. Delmas JOURNAL OF CLINICAL DENSITOMETRY
- Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate
- (2008) R. A. Wermers et al. OSTEOPOROSIS INTERNATIONAL
- Combination anabolic and antiresorptive therapy for osteoporosis: Opening the anabolic window
- (2008) John P. Bilezikian Current Osteoporosis Reports
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started